These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 4395151

  • 1. [Comparative effects of a new beta-adrenergic stimulant in asthma].
    Gayrard P, Orehek J, Charpin J.
    Presse Med (1893); 1970 Dec 05; 78(52):2337-8. PubMed ID: 4395151
    [No Abstract] [Full Text] [Related]

  • 2. [Comparative bronchodilator effects of inhaled terbutaline aerosols and other beta-adrenergics].
    Roberts M, Petit JM.
    Acta Tuberc Pneumol Belg; 1971 Dec 05; 62(2):180-91. PubMed ID: 4398796
    [No Abstract] [Full Text] [Related]

  • 3. Comparative study of a new beta-adrenergic stimulant in asthma: salbutamol.
    Gayrard P, Orehek J, Charpin J.
    Postgrad Med J; 1971 Mar 05; 47():Suppl:46-50. PubMed ID: 4396720
    [No Abstract] [Full Text] [Related]

  • 4. [New isoprenaline-derivative (1-(3,5-dihydroxyphenyl)-1-hydroxy-2-1(4-hydroxyphenyl)-isopropyl-aminoethane. Th 1165 a) in therapy of acute cardiovascular and respiratory emergencies].
    Schuster HP, Baum P.
    Arzneimittelforschung; 1969 Dec 05; 19(12):1905-14. PubMed ID: 4393611
    [No Abstract] [Full Text] [Related]

  • 5. [New beta-adrenergic receptor stimulators in the symptomatic treatment of asthma and chronic obstructive bronchial diseases].
    Van Der Straeten M, Lamont H, Pauwels R, Tasson J.
    Acta Tuberc Pneumol Belg; 1974 Dec 05; 65(3-4):384-94. PubMed ID: 4156900
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of a new B 2 adrenergic receptor stimulant, terbutaline, in bronchial asthma. I. Subcutaneous comparison with epinephrine.
    Glass P, Dulfano MJ.
    Curr Ther Res Clin Exp; 1973 Apr 05; 15(4):141-9. PubMed ID: 4144566
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of a new B 2 adrenergic receptor stimulant, terbutaline, in bronchial asthma. II. Oral comparison with ephedrine.
    Dulfano MJ, Glass P.
    Curr Ther Res Clin Exp; 1973 Apr 05; 15(4):150-7. PubMed ID: 4144567
    [No Abstract] [Full Text] [Related]

  • 8. [beta2-Sympathomimetics: dangers in asthma therapy? Lessons from the SMART1 Study].
    Riedl-Seifert R.
    Dtsch Med Wochenschr; 2007 Mar 23; 132(12):633; author reply 633-4. PubMed ID: 17357910
    [No Abstract] [Full Text] [Related]

  • 9. Studies on Terbulaline, a new selective bronchodilating agent. Introductory remarks.
    Acta Med Scand Suppl; 1970 Mar 23; 512():7-9. PubMed ID: 4396164
    [No Abstract] [Full Text] [Related]

  • 10. [Effects of a beta-adrenergic stimulant: Salbutamol, on spontaneous or induced bronchial obstruction in asthma].
    Orehek J, Gayrard P, Charpin J.
    Mars Med; 1972 Mar 23; 109(11):713-7. PubMed ID: 4145413
    [No Abstract] [Full Text] [Related]

  • 11. Bronchodilator effects of Quinterenol sulfate--a preliminary clinical study.
    Bleecker E, McKinney W, Lyons H, Steen SN.
    Anesth Analg; 1969 Mar 23; 48(1):7-9. PubMed ID: 4883832
    [No Abstract] [Full Text] [Related]

  • 12. [Influence of baseline value of respiratory function on the bronchodilator effect of beta-adrenergic stimulant in asthma].
    Gayrard P, Orehek J, Charpin J.
    Respiration; 1972 Mar 23; 29(3):247-56. PubMed ID: 4403478
    [No Abstract] [Full Text] [Related]

  • 13. [Comparative evaluation of the bronchodilator effects and cardiovascular effects of 3 beta adrenergic stimulants in bronchial asthma--comparison of isoproterenol, metaproterenol and salbutamol].
    Matsumoto S, Tanaka Y, Wagatsuma Y, Miura R, Umezu A.
    Arerugi; 1971 Aug 23; 20(8):599-609. PubMed ID: 4398383
    [No Abstract] [Full Text] [Related]

  • 14. [The place of a new bronchodilator agent (Th 152, Alupent) in the treatment of chronic respiratory insufficiency].
    Vidal J, Guin JJ, Cambon G.
    Therapie; 1966 Aug 23; 21(5):1371-86. PubMed ID: 5976779
    [No Abstract] [Full Text] [Related]

  • 15. [Duration of the therapeutic effect of a beta 2 stimulant (procaterol hydrochloride) in patients with asthmatiform bronchopathies].
    Cammarata A, Mazzarella G, Grella E, Liccardo G.
    Arch Monaldi Mal Torace; 1988 Aug 23; 43(2):131-40. PubMed ID: 2908377
    [No Abstract] [Full Text] [Related]

  • 16. Adrenergic agonists and bronchodilator aerosol therapy in asthma.
    Shim C.
    Clin Chest Med; 1984 Dec 23; 5(4):659-68. PubMed ID: 6151440
    [Abstract] [Full Text] [Related]

  • 17. Assessment of bronchodilator drugs on asthmatic out-patients by daily measurements of the peak expiratory flow rate.
    Heaf PJ, Mattila MJ.
    Arzneimittelforschung; 1969 Dec 23; 19(12):1927-9. PubMed ID: 4908261
    [No Abstract] [Full Text] [Related]

  • 18. Drug therapy: Bronchodilator therapy (first of two parts).
    Webb-Johnson DC, Andrews JL.
    N Engl J Med; 1977 Sep 01; 297(9):476-82. PubMed ID: 69991
    [No Abstract] [Full Text] [Related]

  • 19. Double-blind evaluation of an anti-asthmatic agent.
    Unger DL, Unger L, Temple DE.
    Ann Allergy; 1967 Oct 01; 25(10):575-7. PubMed ID: 4861739
    [No Abstract] [Full Text] [Related]

  • 20. Antiasthmatic drugs.
    Cuddy PG.
    Mo Med; 1984 Nov 01; 81(11):715-20. PubMed ID: 6150431
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.